GENE-ENGINEERED FOOD COVER-UP
EXECUTIVE DIRECTOR OF ALLIANCE FOR BIO-INTEGRITY TO CHALLENGE U.S. FOOD & DRUG ADMINISTRATION (FDA) OFFICIALS AT NOVEMBER 30TH MEETING ON GENETICALLY ENGINEERED FOODS IN WASHINGTON, D.C.
WILL CONFRONT AGENCY WITH EVIDENCE IT COVERED-UP MEMORANDA FROM FDA EXPERTS WARNING ABOUT UNIQUE HEALTH RISKS OF BIOTECH FOODS
PHOTOCOPIES OF THESE INTERNAL FDA DOCUMENTS NOW PUBLISHED ON ALLIANCE'S WEBSITE: http://www.biointegrity.org
FDA Commissioner Dr. Jane Henney and her top officials will receive strong criticism of the agencyís policy on genetically engineered foods >from a public interest attorney at the open meeting to be held by the agency in Washington, D.C. on November 30. Steven M. Druker, executive director of the Alliance for Bio-Integrity, will fault the FDA for ignoring scientifically justified safety concerns in approving genetically engineered foods.
He has been invited to present his views as a member of the panel on Scientific, Safety, and Regulatory Issues.
His criticisms will be aired on the day the World Trade Organization conference starts in Seattle, with the U.S. delegation insisting that FDA policy on genetically engineered foods is science-based and that widespread concerns in Europe and Asia are unscientific and irrational.
Mr. Druker will specifically critique the FDA for turning its back to repeated warnings from its own scientists about the unique risks of genetically engineered foods and for then proclaiming itself "...not aware of any information showing that foods derived by these new methods differ from other foods in any meaningful or uniform way."
These warnings recently came to light when the FDA was required to disclose its internal files during the course of a lawsuit headed by Drukerís organization, Alliance for Bio-Integrity, et al. v. Shalala et al.
The suit, which is pending in U.S. District Court in Washington, D.C., demands that the FDA institute mandatory safety testing and labeling of all genetically engineered foods. Mr. Druker organized an unprecedented coalition of eminent scientists and religious leaders to stand as plaintiffs, and he is also serving as one of the attorneys.
After Druker and co-panelists have made their statements, Commissioner Henney and other FDA officials will have an opportunity to dialogue with them.
The panel discussion will occur during the morning session, which runs from 10:00 A.M. until 1 P.M at the Cohen Auditorium in the Wilbur J. Cohen Building, 330 Independence Ave S.W., Washington, D.C.
Note: Exact copies of several FDA documents expressing concern about risks of bioengineered foods are now on the Alliance for Bio-Integrity website: www.biointegrity.org
| Top or Page